Hamed Kamal
CIK 0001946366
Chief Medical Officer
Filings
4
Latest Feb 5, 2024
Issuers covered
1
Showing
4 of 4
Page 1
Track record
2 of 2 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 2 | 50% | -1.2% | -1.2% | +12.4% | -14.8% |
| 90 days | 2 | 50% | -3.8% | -3.8% | +3.1% | -10.7% |
| 180 days | 2 | 50% | -15.9% | -15.9% | +3.1% | -34.9% |
| 365 days | 2 | 50% | +20.9% | +20.9% | +44.8% | -3.1% |
Issuers
Companies where Hamed Kamal has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| SPRO | Spero Therapeutics, Inc. | 4 | Feb 5, 2024 |
All filings
4 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|